Literature DB >> 19609867

Simultaneous assay of sildenafil and desmethylsildenafil in neonatal plasma by ultra-performance liquid chromatography-tandem mass spectrometry.

Bregje C Witjes1, Maurice J Ahsman, Bart C van der Nagel, Dick Tibboel, Ron A Mathot.   

Abstract

Sildenafil is used to treat pulmonary hypertension in neonatal and pediatric patients. Pharmacokinetic studies in these patients are complicated by the limited sample volume. We present the validation results of an assay method to quantitate sildenafil and desmethylsildenafil simultaneously in 50 microL of plasma. Deuterated sildenafil was used as an internal standard. After liquid-liquid extraction, analytes were separated on an ultra-performance liquid chromatography (UPLC)-column and quantified via tandem mass spectrometry. The calibration range was linear, with acceptable accuracy and a precision of <15% for both compounds. The lower limits of quantification were 1 ng/mL. Matrix effects were present, but inter-plasma batch variability was under 12%. The method was successfully applied to samples from a pharmacokinetic study into sildenafil pharmacokinetics in neonates, making maximum use of the limited number and amount of plasma samples available. (c) 2009 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19609867     DOI: 10.1002/bmc.1268

Source DB:  PubMed          Journal:  Biomed Chromatogr        ISSN: 0269-3879            Impact factor:   1.902


  2 in total

1.  Oral versus intravenous sildenafil for pulmonary hypertension in neonates: a randomized trial.

Authors:  Chinmay Chetan; Pradeep Suryawanshi; Suprabha Patnaik; Naharmal B Soni; Chandra Rath; Prince Pareek; Bhvya Gupta; Reema Garegrat; Arjun Verma; Yogen Singh
Journal:  BMC Pediatr       Date:  2022-05-27       Impact factor: 2.567

2.  Antenatal sildenafil citrate treatment increases offspring blood pressure in the placental-specific Igf2 knockout mouse model of FGR.

Authors:  L J Renshall; E C Cottrell; E Cowley; C P Sibley; P N Baker; E B Thorstensen; S L Greenwood; M Wareing; M R Dilworth
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-12-06       Impact factor: 4.733

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.